News for MARVEL BIOSCIENCES CORP (MRVL.V)

February 28, 2025 (Investorideas.com Newswire) Investorideas.com, a global news source and expert investing resource, announces today's roundup of stocks added ...

Marvel Biosciences Corp.  and its wholly owned subsidiary, Marvel Biotechnology Inc. , is pleased to announce a collaboration with Professor Emmanuel Planel of Laval University to study the acute...

Calgary, Alberta - January 6, 2023 (Newsfile Corp.) (Investorideas.com Newswire) Marvel Biosciences Corp. (TSXV: MRVL) and its wholly owned subsidiary, Marvel B...

/PRNewswire/ -- FinancialNewsMedia.com News Commentary - Anti-anxiety drugs are medications that are used to treat anxiety disorders that are mainly used to...

Calgary, Alberta - December 16, 2021 (Newsfile Corp.) (Investorideas.com Newswire) Marvel Biosciences Corp. (TSXV: MRVL) and its wholly owned subsidiary, Marvel...